Key facts
- Abbott Laboratories is investigating two cyber incidents.
- Unauthorized access occurred at its cancer diagnostics business and LabCentral portal.
- The company stated that its operations were not affected.
- No sensitive customer or business information was exposed.
- LabCentral contained publicly available technical product reference documents.
Abbott Laboratories is investigating two separate cyber incidents that involved unauthorized access to some internal systems. The first incident affected its cancer diagnostics business, while the second involved its LabCentral portal, which is externally facing and third-party hosted. The medical device maker emphasized that its operations were not impacted by either incident, and no other businesses, sites, or systems were affected by the breach at the cancer diagnostics unit. Legacy Exact Sciences systems were confirmed to be separate from Abbott's systems.
The LabCentral portal, used by Abbott's core laboratory diagnostics business, also experienced unauthorized access. However, Abbott stated there was no impact on its businesses or customers, and no sensitive customer or business information was known to be exposed. The company clarified that LabCentral contained publicly available technical product reference documents, such as operating manuals and troubleshooting checklists, but no proprietary or sensitive data.
Abbott has taken steps to address the matters, engaged outside cybersecurity experts and law enforcement, and is continuing its investigation into what information may have been accessed. The company does not anticipate any material impact on its business or financial results from these incidents.